Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Relationship of CYP3A4*1B Single Nucleotide Polymorphism to the Efficiency and Safety Profiles of Haloperidol in Patients Enduring Acute Alcoholic Hallucinosis.
Parkhomenko AA, Zastrozhin MS, Skryabin V, Petukhov AE, Pozdniakov SA, Ivanchenko VA, Zaytsev IA, Bure IV, Bochkov PO, Akmalova KA, Smirnov VV, Bryun EA, Sychev DA. Parkhomenko AA, et al. Among authors: bochkov po. Psychopharmacol Bull. 2023 Dec 4;53(4):8-14. Psychopharmacol Bull. 2023. PMID: 38076668
Relationship of the 1846G > A Polymorphism of the CYP2D6 Gene to the Equilibrium Concentration Levels of Haloperidol in Patients with Acute Alcoholic Hallucinosis.
Parkhomenko AA, Zastrozhin MS, Skryabin V, Petukhov AE, Pozdniakov SA, Ivanchenko VA, Zaytsev IA, Bure IV, Bochkov PO, Akmalova KA, Smirnov VV, Bryun EA, Sychev DA. Parkhomenko AA, et al. Among authors: bochkov po. Psychopharmacol Bull. 2023 Dec 4;53(4):15-22. Psychopharmacol Bull. 2023. PMID: 38076663
Influence of ABCB1, CYP3A5 and CYP3A4 gene polymorphisms on prothrombin time and the residual equilibrium concentration of rivaroxaban in patients with non-valvular atrial fibrillation in real clinical practice.
Sychev DA, Sokolov AV, Reshetko OV, Fisenko VP, Sychev IN, Grishina EA, Bochkov PO, Shevchenko RV, Abdullaev SP, Denisenko NP, Ivashchenko DV, Sozaeva ZA, Kachanova AA. Sychev DA, et al. Among authors: bochkov po. Pharmacogenet Genomics. 2022 Dec 1;32(9):301-307. doi: 10.1097/FPC.0000000000000483. Epub 2022 Oct 13. Pharmacogenet Genomics. 2022. PMID: 36256705
MicroRNAs as novel biomarkers for rivaroxaban therapeutic drug monitoring.
Rytkin E, Bure IV, Bochkov PO, Akmalova KA, Mirzaev KB, Cherniaeva MS, Ostroumova OD, Smirnov VV, Grishina EA, Saribekian AG, Sychev IN, Sychev DA. Rytkin E, et al. Among authors: bochkov po. Drug Metab Pers Ther. 2021 Aug 13;37(1):41-46. doi: 10.1515/dmpt-2021-0118. Drug Metab Pers Ther. 2021. PMID: 35385896
Metabolism of a New Dipeptide Neuroprotector in Rats.
Kolyvanov GB, Bochkov PO, Litvin AA, Shevchenko RV, Podol'ko AL, Kravtsova OY, Kolyasnikova KN, Zherdev VP. Kolyvanov GB, et al. Among authors: bochkov po. Bull Exp Biol Med. 2022 Mar;172(5):579-582. doi: 10.1007/s10517-022-05440-3. Epub 2022 Mar 30. Bull Exp Biol Med. 2022. PMID: 35352249
MicroRNAs as novel biomarkers for rivaroxaban therapeutic drug monitoring.
Rytkin E, Bure IV, Bochkov PO, Akmalova KA, Mirzaev KB, Cherniaeva MS, Ostroumova OD, Smirnov VV, Grishina EA, Saribekian AG, Sychev IN, Sychev DA. Rytkin E, et al. Among authors: bochkov po. Drug Metab Pers Ther. 2021 Aug 13. doi: 10.1515/dmdi-2021-0118. Online ahead of print. Drug Metab Pers Ther. 2021. PMID: 34390638
CYP2C19*17 May Increase the Risk of Death Among Patients with an Acute Coronary Syndrome and Non-Valvular Atrial Fibrillation Who Receive Clopidogrel and Rivaroxaban.
Sychev DA, Baturina OA, Mirzaev KB, Rytkin E, Ivashchenko DV, Andreev DA, Ryzhikova KA, Grishina EA, Bochkov PO, Shevchenko RV. Sychev DA, et al. Among authors: bochkov po. Pharmgenomics Pers Med. 2020 Jan 23;13:29-37. doi: 10.2147/PGPM.S234910. eCollection 2020. Pharmgenomics Pers Med. 2020. PMID: 32158254 Free PMC article.
19 results